Viking Therapeutics (VKTX) Current Leases (2019 - 2025)
Viking Therapeutics (VKTX) has disclosed Current Leases for 7 consecutive years, with $137000.0 as the latest value for Q4 2025.
- Quarterly Current Leases fell 71.98% to $137000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $137000.0 through Dec 2025, down 71.98% year-over-year, with the annual reading at $137000.0 for FY2025, 71.98% down from the prior year.
- Current Leases hit $137000.0 in Q4 2025 for Viking Therapeutics, down from $437000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $498000.0 in Q1 2025 to a low of $29000.0 in Q4 2021.
- Historically, Current Leases has averaged $302500.0 across 5 years, with a median of $311500.0 in 2023.
- Biggest five-year swings in Current Leases: plummeted 91.21% in 2021 and later soared 948.28% in 2022.
- Year by year, Current Leases stood at $29000.0 in 2021, then skyrocketed by 948.28% to $304000.0 in 2022, then rose by 6.58% to $324000.0 in 2023, then skyrocketed by 50.93% to $489000.0 in 2024, then plummeted by 71.98% to $137000.0 in 2025.
- Business Quant data shows Current Leases for VKTX at $137000.0 in Q4 2025, $437000.0 in Q3 2025, and $468000.0 in Q2 2025.